Introduction
Platelets are abundant at sites of wound and fracture healing and are exposed to the varying pH levels as the healing process progress from the initial inflammatory stage to the later reparative stages. The local environment in the initial fracture hematoma is acidic, which later becomes more alkaline as the healing progress [1] . Platelet-rich plasma and platelet derivates contain several potent growth factors and have, therefore, been used for growth stimulation of a variety of mesenchymal cells [2] [3] [4] [5] . Platelet preparations have also been used clinically to stimulate bone formation and wound healing [6] [7] [8] . Previous in vitro studies on supernatants of lysed platelet preparations in different pH buffers have demonstrated increased proliferation of mesenchymal cells particularly when the platelets were prepared in low pH [9, 10] .
The low pH of the buffer simulates the situation in a wound and fracture hematoma, and the space under resorbing osteoclasts. A low pH is also relevant for the environment of a growing tumor, where the pH of the extracellular matrix surrounding the tumour cells is low [11] . The platelets present at a wound and fracture site will be activated or lysed and exposed to the surrounding acidic milieu, and factors activated/solved in low pH initiate and support the healing process and common cell proliferation. Platelets contain bone morphogenetic proteins (BMPs) [12] and the amount of BMP-2, BMP-4, BMP-6 and BMP-7 varies between different platelet donors and it has also been demonstrated that the extracted amount of BMP from lysed platelet concentrates is pH-dependent [13, 14] . BMPs play an important role in recruitment, proliferation, and differentiation of mesenchymal cells [15, 16] , and BMPs have proved to be potent pharmacological agents in the adult skeleton and are being used in spine fusion, fracture repair, and oral and faciomaxillary surgery [17] .
Microarray analysis offers the opportunity for a global survey of gene expression and elucidation of molecular pathways in osteoblast-like cells stimulated by growth factors.
Previous studies on gene expression in bone formation and fracture healing have shown activation of several pathways including Wnt, PTHR, BMP and TGFBR, and, moreover, growth factors genes have been up-regulated, particularly in the early phase of fracture healing [18, 19] .
The objective of this study was to use whole genome microarray gene analysis to identify the genes that are regulated in osteoblast-like cells (hFOB 1.19) when treated with supernatants from lysed platelets prepared in acidic, neutral or alkaline buffers. Our hypothesis is that acidic preparations activates genes and pathways associated with basic cell proliferation, and that neutral preparations will activate genes associated with more osteoblast-like mature cell processes.
Materials and methods

Preparation of lysed platelets in buffer
Platelets, 1.9 × 10 12 cells/L, were harvested from one healthy platelet donor (male, 36 years of age) who previously had a verified release of significant levels of BMPs in supernatants of lysed platelets in buffer (LPB) [13] . (that is, approximately 35% confluence), in a total volume of 10 mL/plate and medium was changed after 24 h to serum-free conditions. Medium was removed after an additional incubation of 24 h and replaced with medium including 18% of the three different preparations of LPB (i.e., at pH 5.4, 7.4, and 7.9). The acidic LPB was brought to neutral pH by adding 2 M NaOH and all LPBs were sterilized through 0.22 mm syringe filters (Sartorius AG, Goettingen, Germany). The hFOB cells were grown for 24 h before isolation of total RNA. Identical culture conditions (including 4% bovine serum albumin) were used for the hFOB control cells except that the platelet concentrate was replaced by 0.9% NaCl.
Isolation of total RNA
RNA was prepared from three controls, two LPB 5.4, two LPB 7.4 and two LPB 7.9 preparations, using Trizol reagent (Invitrogen, Pacely, Scotland) followed by purification on conditions were according to the manufacturer's instructions. Glyceraldehyde 3-phosphate dehydrogenase was amplified as an internal standard. Data were calculated using the comparative Ct method which presents the data as a fold-difference in expression levels relative to a calibrator sample [21] .
Microarray and statistical analysis
Labeled cRNA was hybridized to Human Genome U133 Plus 2.0 Chips and scanned using an Affymetrix GeneChip 7G Scanner. Initial analysis and CEL data files were produced using the Affymetrix GeneChip Operating Software (GCOS) ver. 1.4. Gene expression signal-level data were computed with the robust multi-array average method using default settings, logtransformed, and normalized to total intensities with GeneSpring® GX 10.0.1 using a guided workflow step. Signal intensity values were selected between 20.0 and 100 percentile of each chip and for each individual gene. Significant differentially expressed genes were identified using one-way ANOVA. The Benjamini-Hochberg false discovery rate multiple test correction was applied whenever applicable. Significantly differentially expressed genes by >2.0-fold change at p < 0.005 were used for further analysis. Hierarchical cluster analysis was performed to assess correlations among samples for each identified gene set with Euclidean distance and average linkage statistical methods. Pathway analysis, on genes identified after 20% expression filtering and ANOVA p ≤ 0.05; was carried out to classify genes based on their biological process and molecular function.
Results
Fifty-three genes were identified that were significantly differentially expressed using the criteria described in the Material and Methods section (Table I, Figures 1 and 2 ). Cluster analysis of these 53 genes revealed three clusters that divided them into genes that were: Treatment with LPB 7.4 and LPB 7.9 caused minor up-regulation of some genes (PPAP2B, HSPC111 and PPIF) which are not associated with common pathways (Table I ).
The genes SLC46A3 (rank 19), C1orf104 (rank 22), ACTG2 (rank 18) were greatly downregulated in LPB 7.4 and LPB 7.9 (Table I, Figure 3 ). Some genes belonging to the integrin signaling pathway, i.e., ACTG2 (rank 18), ACTA2 (rank 2), and TNS1 (rank 8), were significantly up-regulated in LPB 5.4 but down-regulated in LPB 7.4 and LPB 7.9 (Table I; Figure 3 ).
Statistical pathway analysis of the genome-wide microarray results from the LPB treated cell cultures displayed 1617 genes associated with 10 significant pathways, i.e., Alpha6beta4 integrin, androgen receptor, EGFR1, hedgehog, IL2, IL4, NOTCH, TGFBR, TNFalpha/NFkB, and Wnt (Table II) . Eight out of these pathways are common with the 10 pathways reported by the Cancer Cell Map [22] , which is a collection of human-focused demonstrated by qPCR (Tables III and IV) .
Eleven genes were selected for qPCR analysis to verify the microarray results from the LPB 5.4 experiments, i.e., 7 up-regulated genes (ACTA2, ACTG2, TNS1, FGF2, TGFB1, CTPS and ANGPLT4) and 1 down-regulated gene (LOH11CR2A), in addition to 3 genes important for hypoxic conditions (CA12, HIF1A and VEGFA). To verify the microarray data, total RNA was extracted from cells treated with LPB 5.4, and the ensuing qPCR analysis confirmed the results of 10 of the 11 genes tested. ACTA2 was down-regulated according to the qPCR but up-regulated in the microarray analysis (Table III) . Previous in vitro studies have demonstrated increased proliferation of fibroblasts [9] and osteoblast-like hFOB 1.19 cells [10] when these cells were stimulated with acidic LPB preparations compared with platelets prepared in neutral pH. In this study, a significant difference was found regarding gene activation in osteoblast-like cells after stimulation with LPB 5.4. Grainger et al. [23] showed that latent TGF-β comprised as much as 95% of the total TGF-β in whole platelets. Latent TGF-β can be activated in low pH in vitro and may explain the stimulatory differences between the different platelet preparations used in this study.
Discussion
Hypothetically, a factor in lysed platelet preparations is activated by the low pH which results in an up-regulation of genes with similar regulatory mechanisms as the HIF1A transcription factor. The activation of this factor could result in extensive changes in gene expression so that cells will adapt to the low pH [11] .
The up-regulated genes in cluster 1 (i.e., the genes up-regulated in the cultures stimulated with LPB 5.4) were represented in the significant pathways, while the significant genes of LPB 7.4 and LPB 7.9 were not. Thus, the stimuli from the LPB 5.4 preparations induced activation of several genes and pathways responsible for cell proliferation, such as regulation of angiogenesis, inflammatory processes and tumor genesis. The VEGFA, HIF1A, ANGPTL4 and CA12 genes (all associated with hypoxia) were up-regulated after stimulation with LPB 5.4 and followed the same pattern as the genes associated with cluster 1.
Our results indicate that factors in the acidic LPB start processes in the cell cultures that involve increased proliferation via 10 significant pathways, of which eight are common with the cancer cell proliferating pathways according to the Cancer Cell Map [22] . The environment of tumors, the initial stage of wound and fracture sites and the sub osteoclastic space are acidic and hypoxic, the content of lysed platelets in these sites would be exposed to regulates the expression of multiple mRNA sequences, and one mRNA can be regulated by multiple microRNA sequences [27] . Many of these microRNAs modulate major proliferation pathways that have relevant implications not only in physiological or developmental processes but also in tumour progression or cancer therapy [28] . Asangani et al. [29] demonstrated that MRNA21 negatively regulates the tumor suppressor gene PDCD4 resulting in increased tumor activity. Lu et al. [30] also found that MRNA21 function as an oncogene by a mechanism that involves translational repression of the tumor suppressor PDCD4. LPB 5.4 resulted in up-regulation of MIRN21 and weakly down-regulated PDCD4 in contrast to controls where MIRN21 was down-regulated and PDCD4 was up-regulated. This indicates that platelets in acidic conditions may release factors that down-regulate tumor suppressor genes which facilitate tumor growth.
Concerning the comparison between LPB 5.4 and LPB 7.4/LPB 7.9, there were a surprisingly low number of genes up-regulated in LPB 7.4 and hardly any significant differences between LPB 7.4 and LPB 7.9. Interestingly, ACTG2, ACTA2 and TNS1 (Table   I) Comparisons with in vivo studies on fracture healing with in vitro model are difficult.
However, Rundle et al. [19] found early up-regulation of TGF- and VEGF, consistent with previous fracture studies; which was an important result of our in vitro model in addition to the up-regulation of integrins. The traditional markers of osteoblastic differentiation (i.e., collagen type I, alkaline phosphatase and osteocalcin) were not up-regulated. The signaling PTH and BMP pathways were not up-regulated, which could indicate that 24 hours is too short culture period. Or the cultured cells need other stimuli to up-regulate genes necessary for later osteoblastic differentiation.
In vivo, acidic pH is a consequence of low tissue pO 2 . In a wound or fracture site, where the circulation is damaged, the pO 2 decreases and the wound/fracture hematoma becomes acidic. Platelets present in these fracture sites will thus be exposed to the lower pH, which will result in the release of factors which will improve cell metabolism/proliferation in acidic/hypoxic milieu. The factors released from platelets (under these conditions) will probably contain the same factors as platelets prepared in acidic buffer. The same condition is also present at the vicinity of active osteoclasts.
In conclusion, we identified 53 genes (after stringent filtering prior to statistical Eight of these pathways were common with the 10 pathways reported by the Cancer Cell Map [22] . The other, IL2 and IL4, are involved in inflammatory processes. (Table I) . 
